Arvinas (ARVN) BidaskScore is lowered to Bought

Arvinas, Inc.

The BidaskScore of Arvinas Inc. ARVNARVN shows that the shares of the company are now ARVNStrongly Bought Bought by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Bought since May 21.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.

Arvinas, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.